[{"AccountsPayableCurrent_0_Q2_USD":4901000.0,"MarketableSecuritiesCurrent_0_Q2_USD":136015000.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":91411000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":148000.0,"AccountsReceivableRelatedPartiesCurrent_0_Q2_USD":0.0,"ProceedsFromIssuanceOfDebt_2_Q2_USD":25000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":5718000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":3011000.0,"OtherLiabilitiesCurrent_0_Q2_USD":2536000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-1595000.0,"MarketableSecuritiesNoncurrent_0_Q2_USD":5647000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":65363000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_0_Q2_shares":8890.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":5.03,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q2_USD":5.6,"EarningsPerShareDiluted_1_Q2_USD":0.94,"EarningsPerShareDiluted_2_Q2_USD":0.36,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":81000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q2_USD":5000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":64000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":2158000.0,"DeferredRentCreditNoncurrent_0_Q2_USD":330000.0,"InterestExpenseDebt_2_Q2_USD":1000000.0,"InterestExpenseDebt_1_Q2_USD":600000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":10510000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":30242000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":391791000.0,"DebtInstrumentInterestRateDuringPeriod_2_Q2_pure":0.0808,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":-1497000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-54000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3011000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":402000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.7315,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":0.8396,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":16621000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":9469000.0,"RestrictedCashNoncurrent_0_Q2_USD":15000.0,"RepaymentsOfDebt_2_Q2_USD":10000000.0,"ProceedsFromStockPlans_2_Q2_USD":646000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":91270000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_2_Q2_USD":0.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_1_Q2_USD":0.0,"OtherNoncashIncomeExpense_2_Q2_USD":-322000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":233000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":370000.0,"DebtInstrumentInterestRateDuringPeriod_1_Q2_pure":0.0807,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"InvestmentIncomeNonoperating_1_Q2_USD":384000.0,"IncreaseDecreaseInDeferredCharges_2_Q2_USD":79000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_2_Q2_USD":48860000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q2_USD":48860000.0,"EquitySecuritiesFvNi_0_Q2_USD":49094000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":10562000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":23503000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":60388000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":65363000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":204891000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_0_Q2_USD":25000000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":204493000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":4000.0,"InvestmentIncomeNonoperating_2_Q2_USD":1025000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":26510873.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":29900913.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":91411000.0,"StockholdersEquity_0_Q2_USD":206757000.0,"RevenueFromRelatedParties_2_Q2_USD":2813000.0,"RevenueFromRelatedParties_1_Q2_USD":0.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-185468000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":11265000.0,"ProfitLoss_2_Q2_USD":10277000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":2931000.0,"NetIncomeLoss_1_Q2_USD":29872000.0,"NetIncomeLoss_2_Q2_USD":10277000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-31234000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-15499000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":107121000.0,"LiabilitiesCurrent_0_Q2_USD":35460000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":4520000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":277538000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-1475000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-1196000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-1969000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":17356000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":8643000.0,"CommonStockValue_0_Q2_USD":36000.0,"CommonStockSharesOutstanding_0_Q2_shares":35878928.0,"CommonStockSharesIssued_0_Q2_shares":35878928.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":65348000.0,"AssetsCurrent_0_Q2_USD":258490000.0,"Assets_0_Q2_USD":277538000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":398000.0,"AccountsReceivableNetCurrent_0_Q2_USD":5102000.0,"Liabilities_0_Q2_USD":70781000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.0162,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"InterestPaidNet_2_Q2_USD":649000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":266740.0,"OtherAssetsNoncurrent_0_Q2_USD":2121000.0,"LongTermDebtNoncurrent_0_Q2_USD":24281000.0,"InterestPayableCurrentAndNoncurrent_0_Q2_USD":200000.0,"EarningsPerShareBasic_2_Q2_USD":0.39,"EarningsPerShareBasic_1_Q2_USD":1.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":1286000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":66685.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":8691304.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":200000.0,"AmortizationOfDebtDiscountPremium_1_Q2_USD":100000.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":-413000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":28538279.0,"CommonStockSharesAuthorized_0_Q2_shares":300000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":31777960.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":191165.0,"ShareBasedCompensation_2_Q2_USD":5718000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":34862000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":17243000.0,"PreferredStockValue_0_Q2_USD":null,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"OperatingIncomeLoss_2_Q2_USD":-35597000.0,"OperatingIncomeLoss_1_Q2_USD":-16417000.0,"OperatingExpenses_2_Q2_USD":52218000.0,"OperatingExpenses_1_Q2_USD":25886000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":8000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.0016,"Ticker":"STRO","CIK":"1382101","name":"SUTRO BIOPHARMA, INC.","OfficialName":"Sutro Biopharma Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"326059920.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]